rs151329289

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_020717.5(SHROOM4):​c.1675G>A​(p.Glu559Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000519 in 1,209,155 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 212 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00039 ( 0 hom., 9 hem., cov: 22)
Exomes 𝑓: 0.00053 ( 0 hom. 203 hem. )

Consequence

SHROOM4
NM_020717.5 missense

Scores

3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 0.0650

Publications

4 publications found
Variant links:
Genes affected
SHROOM4 (HGNC:29215): (shroom family member 4) This gene encodes a member of the APX/Shroom family, which contain an N-terminal PDZ domain and a C-terminal ASD2 motif. The encoded protein may play a role in cytoskeletal architecture. Mutations in this gene have been linked to the X-linked Stocco dos Santos syndrome characterized by cognitive disabilities. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2017]
SHROOM4 Gene-Disease associations (from GenCC):
  • X-linked intellectual disability, Stocco dos Santos type
    Inheritance: XL Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • complex neurodevelopmental disorder
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.05225113).
BP6
Variant X-50634398-C-T is Benign according to our data. Variant chrX-50634398-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 436721.
BS2
High Hemizygotes in GnomAd4 at 9 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SHROOM4NM_020717.5 linkc.1675G>A p.Glu559Lys missense_variant Exon 4 of 9 ENST00000376020.9 NP_065768.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SHROOM4ENST00000376020.9 linkc.1675G>A p.Glu559Lys missense_variant Exon 4 of 9 2 NM_020717.5 ENSP00000365188.2
SHROOM4ENST00000289292.11 linkc.1675G>A p.Glu559Lys missense_variant Exon 4 of 10 1 ENSP00000289292.7
SHROOM4ENST00000460112.3 linkc.1327G>A p.Glu443Lys missense_variant Exon 3 of 8 5 ENSP00000421450.1

Frequencies

GnomAD3 genomes
AF:
0.000386
AC:
43
AN:
111437
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000653
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000285
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000716
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000315
AC:
57
AN:
180846
AF XY:
0.000244
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000734
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000634
Gnomad NFE exome
AF:
0.000647
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000533
AC:
585
AN:
1097663
Hom.:
0
Cov.:
33
AF XY:
0.000559
AC XY:
203
AN XY:
363039
show subpopulations
African (AFR)
AF:
0.0000758
AC:
2
AN:
26396
American (AMR)
AF:
0.000199
AC:
7
AN:
35156
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19374
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30179
South Asian (SAS)
AF:
0.0000370
AC:
2
AN:
54024
European-Finnish (FIN)
AF:
0.0000988
AC:
4
AN:
40498
Middle Eastern (MID)
AF:
0.000242
AC:
1
AN:
4134
European-Non Finnish (NFE)
AF:
0.000647
AC:
545
AN:
841828
Other (OTH)
AF:
0.000521
AC:
24
AN:
46074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
32
65
97
130
162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000386
AC:
43
AN:
111492
Hom.:
0
Cov.:
22
AF XY:
0.000267
AC XY:
9
AN XY:
33688
show subpopulations
African (AFR)
AF:
0.0000652
AC:
2
AN:
30676
American (AMR)
AF:
0.000285
AC:
3
AN:
10538
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3511
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2598
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6048
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.000716
AC:
38
AN:
53068
Other (OTH)
AF:
0.00
AC:
0
AN:
1515
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000508
Hom.:
13
Bravo
AF:
0.000348
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00104
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000446
AC:
3
ExAC
AF:
0.000329
AC:
40

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SHROOM4: BP4, BS2 -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Uncertain:2
Jan 29, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 02, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1675G>A (p.E559K) alteration is located in exon 4 (coding exon 4) of the SHROOM4 gene. This alteration results from a G to A substitution at nucleotide position 1675, causing the glutamic acid (E) at amino acid position 559 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
18
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0070
T;T;.
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.78
T;.;T
M_CAP
Uncertain
0.098
D
MetaRNN
Benign
0.052
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L;L;.
PhyloP100
0.065
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.48
N;N;N
REVEL
Benign
0.14
Sift
Uncertain
0.0010
D;D;D
Sift4G
Benign
0.44
T;T;T
Polyphen
1.0
D;D;.
Vest4
0.067
MVP
0.14
MPC
0.12
ClinPred
0.073
T
GERP RS
5.5
Varity_R
0.097
gMVP
0.17
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151329289; hg19: chrX-50377398; COSMIC: COSV56797601; API